| abstract |
The present invention relates to the field of preparation, identification and selection of biological binding molecules, such as antibodies or fragments thereof, and to the use of such biological binding molecules in the diagnosis and treatment of cancers such as, in particular, B cell malignancies. The binding molecule is capable of selectively binding to a B cell receptor having a light chain according to SEQ ID NO. 18. |